Bulletin from the Extraordinary General Meeting in Hansa Biopharma AB (publ)
Lund, Sweden, September 22, 2026. Hansa Biopharma AB (publ), “Hansa” (Nasdaq Stockholm: HNSA), has today on September 22, 2026 held its Extraordinary General Meeting. The Extraordinary General Meeting was held by physical presence of shareholders and with the option for shareholders to exercise their voting rights by a…
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Xer Tech Holding AB Announces Martin Lidgren’s Decision to Step Down from the Board of Directors
- ShaMaran Announces Annual Meeting Voting Results
- Buy-back of shares in MTG during week 38, 2026
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →